Filing Details

Accession Number:
0001400482-17-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-03 15:47:11
Reporting Period:
2017-02-02
Filing Date:
2017-02-03
Accepted Time:
2017-02-03 15:47:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400482 Kubota Pharmaceutical Holdings Co Ltd M?????? () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1016353 H Edward Danse C/O Acucela Inc.
1301 2Nd Ave., Suite 4200
Seattle WA 98101
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-02 1,250 $8.50 74,664 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. On November 30, 2016, the issuer completed its change in place of incorporation, pursuant to which Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation ("Kubota Holdings"), became the publicly traded parent company of the Kubota group of companies. Each issued and outstanding share of common stock of Acucela Inc., a Washington corporation ("Acucela US"), was cancelled and converted into one share of common stock of Kubota Holdings. Pursuant to Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended, Kubota Holdings is the successor issuer to Acucela US.
  2. The issuer's common stock trades on the Tokyo Stock Exchange under the code 4596.
  3. The sale on this Form 4 was effected pursuant to a non-discretionary, Issuer-mandated sell-to-cover arrangement, in order to cover tax withholding incident to the vesting of shares under the reporting person's restricted stock grant.